Dr. Shumeet Banerji (DIN 02787784) is the Founder of Condorcet LP, an advisory and investment firm focused on early and development stage technology companies.
Dr. Banerji retired as CEO of Booz & Company in 2013 after a long career at the firm and its predecessor Booz, Allen, Hamilton. In 2007-08 he co-led the conception, design, and execution of the historic deal separating Booz, Allen, Hamilton, selling the government business to the Carlyle Group and spinning off the global strategy consulting division as Booz & Company. His current activities are all connected by a thread of the impact of technology and data on human life. Condorcet Partners’ primary focus is on the intersection of data with biology and healthcare.
Dr. Banerji was a member of the faculty at the University of Chicago's Graduate School of Business before joining Booz, Allen, and received his PhD from the Kellogg School of Management, Northwestern University, where he has previously served on the Dean’s Advisory Board.
At Reliance Industries Limited, Dr. Banerji is an Independent Director and a member of the Human Resources, Nomination and Remuneration and Risk Management Committee. He is also a Chairman of the Corporate Social Responsibility and Governance Committee.
Dr. Banerji has served on the Board of Directors of Silicon Valley pioneer Hewlett Packard Company and its successor HP, Inc., since 2011. He is an Independent Director of Reliance Jio Infocomm Limited and of Jio Platforms Limited, India’s (and one of the world’s) most ambitious digital platform plays. He also serves on the Board of Directors of Jio’s parent company Reliance Industries Limited. He is a member of the Board of Directors of Felix Pharmaceuticals (Ireland) and of the Panel of Senior Advisors of Chatham House (The Royal Institute of International Affairs, UK). He is an investor in and advisor to Berg Health, Aetion, and Thread Robotics, all in the USA. He has previously served on the Boards of Innocoll (Ireland) and Proteus Digital Health (USA).